About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNANCT04435353

Assessment of the Effectiveness of Vibroacoustic Therapy for Respiratory Failure Caused by COVID 19

Vibroacoustic pulmonary therapy in patients with COVID19 is believed to have a positive effect on oxygen status and a decrease in the duration of respiratory failure

Lead sponsor: Astana Medical University•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Irina Mukatova, PhD

CONTACT

8701 535 96 79 [email protected]

Sponsors

Lead Sponsor

Astana Medical University

This study aims to recruit the required number of patients for statistical identification of the effectiveness of vibroacoustic therapy in patients with COVID 19. Obligatory performance criteria will be presented by the duration of the course of respiratory failure and the duration of mechanical ventilation in the main and control groups. Optional performance criteria will be represented by oximetry values and standardization of laboratory parameters

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. adults
•2. P/F less 300 torr
•3. ARDS by Berlin convention
•4. COVID 19 bilateral pneumonia

Exclusion Criteria

•1. children
•2. acute brain stroke
•3. acute coronary syndrome
•4. pulmonary embolism
•5. implanted pacemaker

Related studies

RECRUITINGPhase 4

Duration of Surfactant Administration and Impact on Stabilisation of Vital Parameters in Very Preterm Neonates: 1 Minutes Versus 5 Minutes

NCT07261787 · Neonates and Preterm Infants, Infant Respiratory Distress Syndrome, and more

Optimizing Care in Critically Ill at UCHealth by Liberalizing the Target O2 in Mechanically-ventilated ICU Patients

NCT06501118 · Respiratory Failure, Acute Hypoxemic Respiratory Failure, and more

Optimising Breathing Support at Extubation in Very Preterm Infants: A Clinical Study

NCT07251790 · Respiratory Distress Syndrome, Newborn, Respiratory Distress Syndrome in Premature Infant

RECRUITINGPhase 3

Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome

NCT06776783 · Respiratory Distress Syndrome, Pre-term Infants

RECRUITINGPhase 1/2

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

NCT04565665 · COVID-19 Infection, COVID-19-Associated Acute Respiratory Distress Syndrome, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 17, 2020Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment200

Start dateMar 2020

Last updatedJun 17, 2020

Condition

Respiratory Distress Syndrome Hypoxemia

Locations shown

Mukatova Irina

Astana, Astana

Center of pulmonology Astana

Astana

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 17, 2020Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions